CD274 and neoplasm: Enhanced controlled cytotoxicity is achieved by equipping oncolytic (HSV-1) with a bi-specific T cell engager (BiTE) connecting PD-L1 (expressed on tumor cells) and CD3ε (expressed on T cells) in malignant hydroperitoneum derived from patients with different cancers [58].